Singapore firm working on experimental cancer drugs plans listing by end-May
HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
